🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, claiming the companies hid potential risks that the pain reliever created to pediatric brain development.

The court filing arrives a month after President Donald Trump advocated an unverified association between consuming Tylenol - alternatively called acetaminophen - throughout gestation and autism in young ones.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic recommended for expectant mothers, and Kenvue, which currently produces it.

In a statement, he stated they "misled consumers by making money from pain and promoting medication ignoring the dangers."

The manufacturer says there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These companies lied for decades, knowingly endangering countless individuals to increase profits," the attorney general, from the Republican party, stated.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the health of women and children in America."

On its online platform, the company also said it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a established connection between using acetaminophen and autism."

Associations representing physicians and healthcare providers share this view.

ACOG has declared paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and fever, which can present major wellness concerns if ignored.

"In multiple decades of studies on the consumption of acetaminophen in gestation, not a single reputable study has successfully concluded that the use of paracetamol in any trimester of pregnancy results in neurodevelopmental disorders in children," the group commented.

This legal action references latest statements from the previous government in asserting the medication is potentially dangerous.

Recently, Trump raised alarms from health experts when he advised women during pregnancy to "resist strongly" not to take acetaminophen when unwell.

The US Food and Drug Administration then issued a notice that medical professionals should consider limiting the usage of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in children has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had vowed in April to conduct "a massive testing and research effort" that would identify the origin of autism in a matter of months.

But experts advised that finding a sole reason of autism - thought by researchers to be the result of a complicated interplay of inherited and external influences - would prove challenging.

Autism is a form of lifelong neurodivergence and disability that influences how persons experience and engage with the surroundings, and is recognized using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is running for the Senate - claims Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the corporations "eliminate any commercial messaging" that asserts acetaminophen is safe for pregnant women.

The court case parallels the grievances of a assembly of parents of minors with autism and ADHD who took legal action against the manufacturers of Tylenol in 2022.

A federal judge rejected the legal action, declaring research from the family's specialists was lacking definitive proof.